Related Experiment Video
Updated: Jul 25, 2025

05:30
Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing
Published on: November 17, 2023
647
Fibrin Adsorption on Cardiovascular Biomaterials and Medical Devices.
Achebe N O Nzulumike1,2, Esben Thormann1
1Department of Chemistry, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark.
ACS Applied Bio Materials
|June 27, 2023
Summary
Stainless steel and fluoropolymers show lower fibrinogen adsorption, reducing thrombosis risk for blood-contacting medical devices. Fibrin morphology differs on metallic versus polymeric surfaces.
Area of Science:
- Biomaterials Science
- Cardiovascular Engineering
- Surface Chemistry
Background:
- Medical devices in blood vessels risk thrombosis due to protein adsorption and clot formation.
- Fibrinogen adsorption and polymerization initiate surface-induced coagulation, posing a challenge for biomaterial design.
- Minimizing thrombotic complications requires understanding surface-dependent fibrinogen recruitment.
Purpose of the Study:
- To characterize thrombogenic properties of cardiovascular biomaterials.
- To quantify surface-dependent fibrinogen adsorption and fibrin formation.
- To analyze fibrin morphologies on different biomaterials and medical devices.
Main Methods:
- Quantified fibrinogen adsorption on various metallic and polymeric biomaterials.
- Analyzed fibrin formation and resulting morphologies.
- Utilized vascular guidewires as clotting substrates to assess device-specific adsorption.
Main Results:
- Stainless steel and amorphous fluoropolymer exhibited significantly lower fibrinogen recruitment compared to other materials.
- Fibrin formed distinct fiber structures on metallic surfaces and fractal branched structures on polymeric surfaces.
- Fibrin adsorption on guidewires depended on exposed surface areas, correlating with stainless steel morphologies.
Conclusions:
- Stainless steel and amorphous fluoropolymer are promising biomaterials for cardiovascular devices due to reduced fibrinogen adsorption.
- Understanding fibrin morphology provides insights into device-surface interactions and thrombogenicity.
- Surface properties and exposed areas of medical devices influence thrombosis risk.
Related Concept Videos
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Fibronectins Connect Cells with ECM
2.5K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
2.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763

